Hopkinson Craig C.insider trades

In SEC Form 4 filings, Hopkinson Craig C. is listed as EVP R&D, Chief Medical Officer of Alkermes plc. (ALKS). In the last 90 days, Hopkinson Craig C. sold $422.9K of Alkermes plc. (ALKS) on the open market and bought none. The sale was reported under a 10b5-1 trading plan.

Companies and roles

Company	Role	Transactions	Last filed
ALKSAlkermes plc.	EVP R&D, Chief Medical Officer	3	Sep 1

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-01

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
ALKSAlkermes plc.	Sep 1	Sep 1	M	5,000	$24.59	$122,950	74,389	Yes	Form 4
ALKSAlkermes plc.	Sep 1	Sep 1	S	9,000	$46.99	Sale −$422,874	65,389	Yes	Form 4
ALKSAlkermes plc.	Sep 1	Sep 1	M · derivative	5,000	$24.59	$122,950	61,276	Yes	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.